Latest close
$340.50
As of Oct 2, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Himalaya Capital Management | 23.39% | 2,451,300 | HELD |
| Oakcliff Capital | 15.55% | 118,161 | HELD |
| Gardner Russo & Quinn | 12.07% | 3,048,077 | TRIMMED (-9.0%) |
| Chou Associates | 11.81% | 72,390 | HELD |
| Egerton Capital | 11.24% | 3,291,594 | TRIMMED (-4.9%) |
| Triple Frond Partners | 9.19% | 291,544 | TRIMMED (-17.5%) |
| Baupost Group | 8.95% | 1,371,931 | ADDED (+16.2%) |
| Appaloosa Management | 8.46% | 1,850,000 | ADDED (+6.8%) |
| Markel Group | 7.40% | 2,749,860 | HELD |
| Giverny Capital | 7.19% | 605,460 | TRIMMED (-2.5%) |
| Kahn Brothers Group | 6.75% | 120,906 | TRIMMED (-0.9%) |
| TCI Fund Management | 6.65% | 9,938,819 | ADDED (+12.3%) |
| Polen Capital Management | 6.59% | 2,165,218 | TRIMMED (-26.5%) |
| Weitz Investment Management | 6.56% | 268,100 | TRIMMED (-17.9%) |
| First Pacific Advisors | 5.82% | 1,333,205 | HELD |
| Vulcan Value Partners | 5.80% | 539,472 | TRIMMED (-20.3%) |
| Mairs & Power Funds | 5.46% | 1,683,439 | ADDED (+4.5%) |
| Ruane Cunniff LP | 5.08% | 924,866 | TRIMMED (-2.7%) |
| Yacktman Asset Management | 4.93% | 1,129,129 | ADDED (+0.2%) |
| Maverick Capital | 4.50% | 1,442,118 | ADDED (+65.2%) |
| First Eagle Investment Management | 4.26% | 7,316,252 | TRIMMED (-1.2%) |
| Matrix Asset Advisors | 3.90% | 135,829 | TRIMMED (-5.6%) |
| H&H International Investment | 3.64% | 1,968,600 | TRIMMED (-46.9%) |
| Century Management | 3.37% | 45,086 | TRIMMED (-2.9%) |
| Berkshire Hathaway | 3.21% | 27,188,433 | ADDED (+658.3%) |
| Dodge & Cox Funds | 2.21% | 11,961,097 | TRIMMED (-2.2%) |
| Causeway Capital Management | 1.21% | 316,217 | TRIMMED (-6.2%) |
| Oakmark Funds | 0.91% | 1,937,306 | ADDED (+118.4%) |
| Davis Advisors | 0.86% | 564,274 | TRIMMED (-16.7%) |
| Torray Funds | 0.29% | 6,019 | HELD |
| Hillman Capital Management | 0.26% | 1,030 | TRIMMED (-8.6%) |
| Semper Augustus | 0.10% | 2,432 | HELD |
| Brave Warrior Advisors | 0.03% | 3,790 | HELD |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
| Institutions holding | 5,195 of 8,857 filers |
| Long-only filers among them | 5,180 |
| Change vs 2026 Q1 | +176 net · 2,065 entered · 1,889 exited |
| Shares reported, all filers | 3,349,680,702 |
| Reported value, all filers | $1,190.5B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 3, 2026.
1 House members reported buying (2 purchases vs 2 sales). Bought by Democrats. Latest buy: Sep 14, 2026.
Source: U.S. House Clerk STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade. Senate reports are not included yet.
Politicians
· Bought by Members — Last 6 months: bought by a U.S. House member
Financial Screens
· Buffett — Companies with high ROE sustained for more than a decade
· Growth — Revenue up every year for 5 straight years
· Graham — Sound finances and a long run of profits
· O'Neil CAN SLIM — Explosive earnings growth leaders
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Key figures
· Buffett — Latest ROE: 31.8% · Years ROE ≥15% (of 10): 8 · 10-yr avg ROE: 21.7% · Latest net income: $132.2B
· Growth — Latest revenue: $402.8B · 5-yr revenue CAGR: 16.4% · Straight growth years: 11
· Graham — Current ratio: 2.01 · Straight profitable years: 13 · Debt ratio: 0.43 · Latest net income: $132.2B
· O'Neil CAN SLIM — 3-yr EPS growth: 33.3% · ROE: 31.8% · Latest revenue growth: 15.1%
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.29 · Operating cash flow: $164.7B · Net income: $132.2B
· Bought by Members — Members buying: 1 · Buy txns: 2 · Sell txns: 2 · Latest buy: Sep 14, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Super-investor 13F BEST — appeared in 20 of the last 20 quarterly lists; latest 2026 Q2, ranked #4 of 50.
· Politician BEST — appeared in 9 of the last 20 quarterly lists; latest 2025 Q4, ranked #16 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 18 | 61.1% | +4.7% | +3.0% | +1.7% |
| Share count tripled (3x) | 3 | 33.3% | -3.3% | +5.0% | -8.2% |
| Heavy exit — 3+ tracked funds sold out together | 2 | 100.0% | +6.7% | +7.0% | -0.3% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.